Alder BioPharmaceuticals, Inc. Debt to Equity Ratio 2014-2019 | ALDR
Current and historical debt to equity ratio values for Alder BioPharmaceuticals, Inc. (ALDR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Alder BioPharmaceuticals, Inc. debt/equity for the three months ending June 30, 2019 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-06-30 | $0.25B | $0.22B | 1.13 |
| 2019-03-31 | $0.25B | $0.26B | 0.97 |
| 2018-12-31 | $0.21B | $0.21B | 0.99 |
| 2018-09-30 | $0.21B | $0.29B | 0.74 |
| 2018-06-30 | $0.21B | $0.34B | 0.61 |
| 2018-03-31 | $0.20B | $0.40B | 0.50 |
| 2017-12-31 | $0.02B | $0.28B | 0.09 |
| 2017-09-30 | $0.04B | $0.33B | 0.12 |
| 2017-06-30 | $0.04B | $0.22B | 0.16 |
| 2017-03-31 | $0.03B | $0.29B | 0.11 |
| 2016-12-31 | $0.03B | $0.38B | 0.07 |
| 2016-09-30 | $0.02B | $0.43B | 0.04 |
| 2016-06-30 | $0.02B | $0.46B | 0.04 |
| 2016-03-31 | $0.02B | $0.36B | 0.04 |
| 2015-12-31 | $0.01B | $0.39B | 0.03 |
| 2015-09-30 | $0.02B | $0.41B | 0.04 |
| 2015-06-30 | $0.01B | $0.44B | 0.02 |
| 2015-03-31 | $0.01B | $0.24B | 0.03 |
| 2014-12-31 | $0.01B | $0.06B | 0.09 |
| 2014-09-30 | $0.01B | $0.07B | 0.17 |
| 2014-06-30 | $0.05B | $0.04B | 1.39 |
| 2014-03-31 | $0.05B | $-0.04B | -1.45 |
| 2013-12-31 | $0.06B | $-0.03B | -1.84 |
| 2013-09-30 | $0.00B | 0.00 | |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
